Evolent Health, Inc.
Company Stats
- Market Cap
- $394.6M
- as of Sep 30, 2026
- Shares Outstanding
- 113.1M
- Free Float
- 82.0%
Income Statement
- Revenue
- $1.9B
- Operating Income
- -$410.1M
- Net Income
- -$534.5M
- EBITDA
- -$294.3M
- Non-cash Impairment
- $398.0M
- Revenue Growth, 3Y
- 11.5%
Balance Sheet
- Cash & Equivalents
- $151.9M
Returns & Capital
- Share Repurchases
- $40.0M
- Buyback Yield, 3Y Avg
- 3.4%
- SBC, 3Y Avg
- $40.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.9B | — | — |
| FY2024 | $2.6B | — | — |
| FY2023 | $2.0B | $142.4M | 7.3% |
| FY2022 | $1.4B | -$12.1M | -0.9% |
| FY2021 | $908.0M | $38.0M | 4.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 1, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Financial Services Earnings: Demand Strong, Costs Bite Back